John has worked on the political sociology of cost-effectiveness assessment and pharmaceutical pricing policy, particularly in the UK context. His work has focused on how pharmaceutical companies set prices and the adequacy of pricing regulation in the UK and beyond. John has also worked on the extent to which the UK’s National Institute for Clinical Excellence (NICE), now known as the National Institute for Health and Care Excellence, should be regarded as an effective regulatory agency to protect the NHS and the interests of public health, with reference to its regulation of the cost-effectiveness of pharmaceuticals.
John Abraham and Gowree Balendran (2026) ‘Inside the “Black Box” of Pharmaceuticalisation: NICE, the Permissive Principle and the case of Anti-coagulants’ Sociology of Health & Illness 48 (8), 16 October 2026, pp.1-14, doi.org/10.1111/1467-9566.70279
John Abraham and Gowree Balendran (2026) ‘Synthetic Certainization in medical controversy: Evidence synthesis, NICE recommendations and the drug-device complex in stroke prevention’ Journal of Critical Public Health 3: 38-56.
John Abraham and Gowree Balendran (2025) ‘The political sociology of NICE: Investigating pharmaceutical cost-effectiveness regulation in the UK’ Sociology of Health & Illness 47 (1 January 2025), e13878, pp1-14, doi.org/10.1111/1467-9566.13878
Jonathan Guillemot, John Abraham and Anthea Tinker (2025) ‘Understanding trends in osteoporosis drug prescribing in England and France’ Frontiers in Medicine (13 January 2025), pp1-17. Doi 10.3389/fmed.2024.1454150
John Abraham (2009) ‘Governing the pharmaceutical industry and the NHS, 1948-2008’ Journal of Health, Politics, Policy and Law 34: 931-77.
John Abraham (2009) ‘Global health challenges in the pharmaceutical world’ Health Economics, Policy and Law 4: 115-27.
John Abraham (2010) ‘The pharmaceutical industry and medications’ in (eds.) P. Conrad, C. Bird, A. Freemont & S. Timmermans, American Sociological Association Handbook of Medical Sociology, pp. 290-308, Vanderbilt University Press.
John Abraham (2009) ‘The pharmaceutical industry, the State and the NHS’ in (eds.) J. Gabe & M. Calnan, New Sociology of the NHS, pp. 99-120 (London: Routledge).